Physical and chemical stability of iron sucrose in parenteral nutrition

Nutrition in Clinical Practice

Volumn 24, Issue 6, 2009, Pages 733-737

  MacKay, Mark ^a   Rusho, William ^a   Jackson, Daniel ^b   McMillin, Gwendolyn ^c   Winther, Brian ^a  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

Drug nutrient interactions; Minerals trace elements; Outcomes research quality; Parenteral formulas compounding; Parenteral nutrition

Indexed keywords

FERRIC HYDROXIDE SUCROSE; PARENTERAL SOLUTION;

ARTICLE; CHEMICAL COMPOSITION; DRUG STABILITY; HUMAN; MASS SPECTROMETRY; PARENTERAL NUTRITION; PARTICULATE MATTER; PH;

CHEMICAL PRECIPITATION; CRYSTALLIZATION; DRUG STABILITY; GUIDELINES AS TOPIC; HUMANS; INFANT, NEWBORN; IRON-DEXTRAN COMPLEX; PARENTERAL NUTRITION; PARTICULATE MATTER; PHARMACOPOEIAS AS TOPIC;

EID: 74549117843     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533609351528     Document Type: Article

References (16)

1. Mayhew S, Quick M. Compatibility of iron dextran with neonatal parenteral nutrient solutions. Am J Health Syst Pharm. 1997;54:570-571.
2. Vaughn M, Small C. Incompatibility of iron dextran and a total nutrient admixture. Am J Hosp Pharm. 1990;47:1745-1746.
3. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J. Update on adverse events associated with parenteral iron. Nephrol Dial Transplant. 2006;21:378-382.
4. MacKay M, Farr F, Jones K, Eggert L, Jackson D, McDonald C. Pediatric parenteral nutrition via computerized worksheet and automated compounding. Nutr Clin Pract. 2000;15:130-137.
5. Heird WC, Dell RD, Helms RA, et al. Amino acid mixture designed to maintain normal plasma amino acid patterns in infants and children requiring parenteral nutrition. Pediatrics. 1987;80:401-408.
6. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosing Handbook. 15th ed. Hudson, OH: Lexi-Comp; 2008:476-477.
7. Friel JK, Andrews WL, Hall MS, et al. Intravenous iron administration to very-low-birth-weight newborns receiving total and partial parenteral nutrition. JPEN J Parenter Enteral Nutr. 1995;19: 114-118.
8. Venofer iron sucrose injection [package insert]. Shirley, NY: American Regent Laboratories; 2000.
9. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosing Handbook. 15th ed. Hudson, OH: Lexi-Comp; 2008:971-973.
10. Wall GC, Pauly RA. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. Am J Health Syst Pharm. 2008;65:150-153.
11. The United States Pharmacopeia. The National Formulary. Rockville, MD: United States Pharmacopeial Convention; 2008. USP 31: NF 26, 313.
12. The United States Pharmacopeia. The National Formulary. Rockville, MD: United States Pharmacopeial Convention; 2008. USP 31: NF 26, 328.
13. Hanson D, Hendeles L. Guide to total dose intravenous iron dextran. Am J Hosp Pharm. 1974;31:592-595.
14. Reed M, Bertino J, Halpin T. Use of intravenous iron dextran injection in children receiving total parenteral nutrition. Am J Dis Child. 1981;135:829-831.
15. Van Wyck D, Cavallo G, Spinowitz B, et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis. 2000;36:88-97.
16. Hollands J, Foote E, Rodriguez A, Rothschild J, Young S. Safety of high-dose iron sucrose in fusion in hospitalized patients with chronic kidney disease. Am J Health Syst Pharm. 2006;63:731-734.